EARLY CONSUMPTION OF LYCOPENE AND REDUCED INCIDENCE OF PROSTATE CANCER-
A SYSTEMATIC REVIEW
Abstract
Prostate cancer and benign prostatic hyperplasia (BPH) are two common
diseases of the prostate gland. Pharmaceutical drugs are widely used to
treat BPH, which enhance symptoms but are also accompanied by side
effects such as erectile dysfunction, which have a negative impact on
quality of life. Prostate cancer, like other cancers, has a wide range
of treatment options. The effectiveness of these prostate cancer
therapies is determined by the stage of the disease. While the efficacy
of prostate cancer therapies varies, erectile dysfunction, incontinence,
and a lower quality of life are all common side effects. Diet and
lifestyle factors can be helpful in lowering the risk of cancer,
according to preliminary evidence from systematic reviews. Lycopene, a
carotenoid found in a variety of red-colored fruits and vegetables, has
been shown to have powerful antioxidant and pro-oxidant properties. The
existing evidence on the use of lycopene as a prostate disease
prevention agent is examined in this chapter.